ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1169

Cardiac Dysfunction in C57Bl/6J Mice with CKD: Comparison of Dietary Adenine and 5/6 Nephrectomy Models

Session Information

  • CKD: Mechanisms - 3
    October 26, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Zhao, Yitong, Division of Nephrology, Department of Medicine, University of California-Irvine, Irvine, California, United States
  • Yang, Karen, University of California Riverside School of Medicine, Riverside, California, United States
  • Wu, Hongmei, Division of Nephrology, Department of Medicine, University of California-Irvine, Irvine, California, United States
  • Liu, Han, Division of Nephrology, Department of Medicine, University of California-Irvine, Irvine, California, United States
  • Velez, Leandro, University of California Irvine Department of Biological Chemistry, Irvine, California, United States
  • Kim, Jin Kyung, Division of Cardiology, Department of Medicine, University of California-Irvine, Irvine, California, United States
  • Seldin, Marcus, University of California Irvine Department of Biological Chemistry, Irvine, California, United States
  • Lau, Wei Ling, Division of Nephrology, Department of Medicine, University of California-Irvine, Irvine, California, United States
Background

Cardiovascular disease (CVD) is the leading cause of death among patients with chronic kidney disease (CKD). Gut-derived uremic toxins contribute to vascular injury and cardiomyopathy in CKD. In this study, we compared echocardiogram parameters between dietary adenine and 5/6 nephrectomy CKD models and examined associations with gut-derived uremic toxins stratified by sex.

Methods

Male and female adult C57Bl/6J mice were randomly assigned to control, adenine-induced CKD and 5/6 nephrectomy CKD groups. Echocardiography was performed on all mice at 5 weeks after CKD induction. Serum creatinine, cystatin C and gut-derived uremic toxins (trimethylamine N-oxide, TMAO; indoxyl sulfate, IS; and p-cresyl sulfate, pCS) were analyzed at study termination. Data was analyzed using two-way ANOVA and Spearman correlation analysis.

Results

Serum markers of kidney dysfunction (creatinine and cystatin C) were significantly elevated in both CKD models. TMAO was significantly increased in adenine CKD mice, IS was elevated in both CKD models, and pCS was increased in the nephrectomy group. Left ventricular volume was increased in nephrectomy animals. Cardiac output (CO) was decreased in male CKD animals from both models compared to male controls, and ejection fraction (EF) was decreased in male 5/6 nephrectomy mice (figure). Female controls had lower CO than male counterparts, and female CKD animals were not significantly different from female controls in terms of CO and EF. In female animals, higher serum pCS and IS were positively correlated with increased left ventricular volume; higher pCS were inversely correlated with EF (r = -0.501, P<0.05). These associations were not seen in male animals.

Conclusion

Our work highlights sex differences in cardiac function and serum toxin levels in two established preclinical CKD models. Gut-derived uremic toxins may impact cardiorenal pathophysiology in female but not male CKD animals.